Your browser doesn't support javascript.
loading
Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin.
Short, Nicholas J; Richard-Carpentier, Guillaume; Kanagal-Shamanna, Rashmi; Patel, Keyur P; Konopleva, Marina; Papageorgiou, Ioannis; Pemmaraju, Naveen; Borthakur, Gautam; Ravandi, Farhad; DiNardo, Courtney D; Kadia, Tapan M; Kantarjian, Hagop; Lamba, Jatinder K; Daver, Naval.
Afiliação
  • Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Richard-Carpentier G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Patel KP; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Papageorgiou I; Department of Pharmacotherapy & Translational Research, The University of Florida, Gainesville, Florida, USA.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lamba JK; Department of Pharmacotherapy & Translational Research, The University of Florida, Gainesville, Florida, USA.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 95(9): E225-E228, 2020 09.
Article em En | MEDLINE | ID: mdl-32356320
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hematológicas / Polimorfismo de Nucleotídeo Único / Lectina 3 Semelhante a Ig de Ligação ao Ácido Siálico / Proteínas de Neoplasias Limite: Adult / Female / Humans / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hematológicas / Polimorfismo de Nucleotídeo Único / Lectina 3 Semelhante a Ig de Ligação ao Ácido Siálico / Proteínas de Neoplasias Limite: Adult / Female / Humans / Male Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos